IHA special colloquium by Professorial Fellow John Kanis

Published: Wednesday 26th October 2016

IHA is pleased to invite ACU colleagues to a special presentation by visiting Professorial Fellow John Kanis, as part of our Live Long Live Well colloquium series.

Title: Towards an operational definition of sarcopenia

When: 2 to 3pm (AEST), Friday 11 November

Where: Rm 6.02, Level 6, 215 Spring Street Melbourne

How: In person, teleconference, or via audio-visual link from an ACU location

Please contact IHA@acu.edu.au / 03 9230 8170 to register your interest in attending, and to obtain dial-in meeting IDs for joining the colloquium via A/V link from an ACU location, or via teleconference from another location.

ACU colleagues are encouraged to dial in from a campus A/V meeting room, or by using Polycom Realpresence on their computer desktop. A/V room bookings can be requested via Servicedesk@acu.edu.au or by calling 07 3623 7272. The Servicedesk can also assist with Polycom installation on your PC or laptop.

Background:

Professor John A. Kanis is Emeritus Professor in Human Metabolism, and Director of the Centre for Metabolic Bone Diseases (Formerly WHO Collaborating Centre), University of Sheffield, UK and Professorial Fellow at the Australian Catholic University.

He is the current President of the International Osteoporosis Foundation, member of its Committee of Scientific Advisors and Chairman of the Working Group on Epidemiology and Quality of Life. Professor Kanis’ research interests are largely related to disorders of skeletal metabolism including osteoporosis, sarcopenia, Paget's disease of bone, hyperparathyroidism, renal osteodystrophy and neoplasia affecting the skeleton. Contributions to research include cell biology, histomorphometry of bone, assessment and treatment of bone disorders, guideline development, health technology assessment, epidemiology, regulatory affairs and health economics.

He is the Editor in Chief of Osteoporosis International and Archives of Osteoporosis, and serves on the editorial board of several journals. He is the author of more than 1000 papers, chapters and books on bone disease and metabolism. His current major interest is in the development of risk assessment algorithms and the formulation of practice guidelines in many regions of the world

Return